What does this site mean for you?

Who provides the information and who benefits?

The people who own QC Kinetix Phoenix-area clinics also own this site, so their clinic business may gain when you book a consultation after reading the hip information here. Keep that business link in mind when you read about a clinic procedure. This site doesn't quote patient ratings or reviews.

The pages offer broad health information, not a diagnosis for your hip. Your doctor can check your movement, sore areas, medicines, and health risks. Get urgent care for emergency warning signs instead of using an online form. Ask the clinic for a current written price before any procedure.

Bring short notes about walking, sleep, falls, and past hip care to a visit. Ask what the doctor thinks is sore and whether an X-ray is needed. For PRP, ask whose blood is used, how it is prepared, and who performs the procedure. Ask about harms, total cost, and later care.

No research can tell you the amount of relief you'll feel or how long it will last. Knee results may not hold true for a hip. Relief also isn't proof that cartilage has returned. Those are the main limits to remember when you weigh the answer.

Sources

1. A dual systematic review compared the RCT evidence on injectable orthobiologics for knee OA with how news media describe it. Of 14 qualifying RCTs, 8 showed significant pain improvement and 10 function improvement, with frequent heterogeneity and risk of bias. Of 124 news articles: 79.0% highlighted benefits, only 29.8% mentioned drawbacks, 37.1% used the term 'stem cell' without specifying the product, 35.5% mentioned commercial entities with no disclosure, and 66.1% were favourable in tone. The authors conclude this disconnect encourages unrealistic expectations.

   Zhang EJX, et al. — Disparities in Evidence and Media Portrayal of Injectable Orthobiologics for Knee Osteoarthritis: A Systematic Review of Randomized Trials and News Media.. Orthopaedic journal of sports medicine, 2026. DOI: 10.1177/23259671261443876.

2. FDA states plainly that no stem cell, exosome, stromal vascular fraction, umbilical cord blood, Wharton's jelly or amniotic-fluid product has been approved for the treatment of ANY orthopedic condition - it names osteoarthritis, tendonitis, disc disease, tennis elbow, back pain, hip pain, knee pain, neck pain and shoulder pain individually. The only FDA-approved stem cell products in the United States are cord-blood-derived blood-forming stem cells for disorders of the hematopoietic system, and there are currently no FDA-approved exosome products.

   US Food and Drug Administration, Center for Biologics Evaluation and Research — Consumer Alert on Regenerative Medicine Products Including Stem Cells and Exosomes. FDA, 2020.

3. A Bayesian network meta-analysis of 11 randomized trials (1353 patients) in hip osteoarthritis found that at 2-4 months and 6 months NO injectable - corticosteroid, hyaluronic acid or platelet-rich plasma - significantly outperformed a saline placebo injection for pain or function. Pooled change from baseline exceeded the minimal clinically important difference in every arm including placebo.

   Gazendam A, et al. — Intra-articular saline injection is as effective as corticosteroids, platelet-rich plasma and hyaluronic acid for hip osteoarthritis pain: a systematic review and network meta-analysis of randomised controlled trials.. British Journal of Sports Medicine, 2021. DOI: 10.1136/bjsports-2020-102179.